Physician profile
Samad Oraee
NPI 1235156084
$8,257.55
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,181 · 2020: $5,817 · 2021: $1,259.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $4,989.95 | 2020 | |
| Collegium Pharmaceutical, INC. | $472.99 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $312.31 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $303.66 | 2019-2021 | |
| Lilly USA, LLC | $287.84 | 2019-2021 | |
| Amgen INC. | $264.60 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $223.90 | 2019-2021 | |
| Abbvie INC. | $142.64 | 2021 | |
| Novartis Pharmaceuticals Corporation | $134.66 | 2019-2021 | |
| Daiichi Sankyo INC. | $123.30 | 2019 | |
| Biogen, INC. | $121.32 | 2021 | |
| Alexion Pharmaceuticals, INC. | $89.62 | 2019 | |
| Lundbeck LLC | $83.82 | 2020-2021 | |
| Pfizer INC. | $68.58 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $60.47 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Upsher-Smith Laboratories LLC | $60.35 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $53.20 | 2021 | |
| Arbor Pharmaceuticals, INC. | $51.19 | 2020-2021 | |
| Biodelivery Sciences International, INC. | $43.28 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $37.55 | 2019 | |
| Janssen Pharmaceuticals, INC | $36.74 | 2021 | |
| Horizon Therapeutics Plc | $35.68 | 2020-2021 | |
| Ibsa Pharma INC. | $34.35 | 2021 | |
| Assertio Therapeutics, INC. | $33.68 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $28.25 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.79 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $24.79 | 2019-2020 | |
| Redhill Biopharma INC. | $24.00 | 2020 | |
| Forte Bio-Pharma LLC | $19.51 | 2019-2020 | |
| Emd Serono, INC. | $16.39 | 2021 | |
| Promius Pharma LLC | $14.53 | 2019 | |
| Amneal Pharmaceuticals LLC | $14.21 | 2020 | |
| Zyla Life Sciences, INC. | $14.02 | 2019 | |
| Shionogi INC | $11.38 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samad Oraee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.